相似文献
1
Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.
Thorax. 2004 Dec;59(12):1089-94. doi: 10.1136/thx.2003.015875.
2
Obstructive sleep apnoea-hypopnoea syndrome and arterial hypertension.
Acta Cardiol. 2006 Feb;61(1):95-102. doi: 10.2143/AC.61.1.2005146.
3
Prevalence of hypertension and circadian blood pressure variations in patients with obstructive sleep apnoea-hypopnoea syndrome.
J Int Med Res. 2014 Jun;42(3):773-80. doi: 10.1177/0300060513516756. Epub 2014 Mar 20.
4
Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial.
BMJ. 2010 Nov 24;341:c5991. doi: 10.1136/bmj.c5991.
5
[Cardiovascular consequences of obstructive sleep apnoea syndrome].
Praxis (Bern 1994). 2010 Jan 20;99(2):117-22. doi: 10.1024/1661-8157/a000014.
6
The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea.
Hypertension. 2011 Mar;57(3):549-55. doi: 10.1161/HYPERTENSIONAHA.110.165969. Epub 2011 Jan 17.
7
Obstructive sleep apnoea syndrome and obesity in children.
Hong Kong Med J. 2004 Feb;10(1):44-8.
8
Obstructive sleep apnea and cardiovascular disease: a perspective and future directions.
Prog Cardiovasc Dis. 2009 Mar-Apr;51(5):434-51. doi: 10.1016/j.pcad.2009.01.002.
9
Comparison of continuous positive airway pressure and bosentan effect in mildly hypertensive patients with obstructive sleep apnoea: A randomized controlled pilot study.
Respirology. 2016 Apr;21(3):546-52. doi: 10.1111/resp.12713. Epub 2015 Dec 8.
10
Managing hypertension in obstructive sleep apnea: the interplay of continuous positive airway pressure, medication and chronotherapy.
J Hypertens. 2010 May;28(5):875-82. doi: 10.1097/HJH.0b013e328336ed85.
引用本文的文献
1
A Prediction Model of Incident Cardiovascular Disease in Patients with Sleep-Disordered Breathing.
Diagnostics (Basel). 2021 Nov 26;11(12):2212. doi: 10.3390/diagnostics11122212.
2
Impact of patient and family engagement in improving continuous positive airway pressure adherence in patients with obstructive sleep apnea: a randomized controlled trial.
J Clin Sleep Med. 2022 Jan 1;18(1):181-191. doi: 10.5664/jcsm.9534.
3
Treatment of sleep-disordered breathing with positional therapy: long-term results.
Sleep Breath. 2019 Dec;23(4):1141-1149. doi: 10.1007/s11325-019-01792-9. Epub 2019 Feb 18.
4
Obstructive Sleep Apnea: From Intermittent Hypoxia to Cardiovascular Complications via Blood Platelets.
Front Neurol. 2018 Aug 3;9:635. doi: 10.3389/fneur.2018.00635. eCollection 2018.
5
Screening for obstructive sleep apnea among hospital outpatients.
PLoS One. 2018 May 30;13(5):e0198315. doi: 10.1371/journal.pone.0198315. eCollection 2018.
6
Sleep-disordered breathing and cardiovascular disease.
Indian Heart J. 2016 Apr;68 Suppl 1(Suppl 1):S69-76. doi: 10.1016/j.ihj.2015.11.018. Epub 2015 Dec 10.
7
The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners.
Clin Mol Allergy. 2015 Apr 15;13(1):4. doi: 10.1186/s12948-015-0009-9. eCollection 2015.
8
Chronic intermittent hypoxia leads to insulin resistance and impaired glucose tolerance through dysregulation of adipokines in non-obese rats.
Sleep Breath. 2015 Dec;19(4):1467-73. doi: 10.1007/s11325-015-1144-8. Epub 2015 Feb 28.
9
Strength training and light physical activity reduces the apnea-hypopnea index in institutionalized older adults.
J Am Med Dir Assoc. 2014;15(11):844-6. doi: 10.1016/j.jamda.2014.08.006. Epub 2014 Oct 5.
10
New insights on obstructive sleep apnea syndrome and related comorbidities in morbidly obese patients submitted to bariatric surgery.
Obes Surg. 2014 Nov;24(11):1995-8. doi: 10.1007/s11695-014-1396-6.
本文引用的文献
1
Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.
Lancet. 2003 Jun 14;361(9374):2017-23. doi: 10.1016/S0140-6736(03)13637-9.
2
Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex.
Eur Respir J. 2003 Feb;21(2):241-7. doi: 10.1183/09031936.03.00035402.
3
Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea.
Circulation. 2003 Jan 7;107(1):68-73. doi: 10.1161/01.cir.0000042706.47107.7a.
4
Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease.
Am J Cardiol. 2002 Jul 1;90(1):15-8. doi: 10.1016/s0002-9149(02)02378-0.
5
Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial.
Lancet. 2002 Jan 19;359(9302):204-10. doi: 10.1016/S0140-6736(02)07445-7.
6
Health consequences of visceral obesity.
Ann Med. 2001 Nov;33(8):534-41. doi: 10.3109/07853890108995963.
7
Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome.
Am J Respir Crit Care Med. 2001 Sep 15;164(6):939-43. doi: 10.1164/ajrccm.164.6.2008010.
8
Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea.
Chest. 2001 Sep;120(3):887-93. doi: 10.1378/chest.120.3.887.
9
Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial.
Ann Intern Med. 2001 Jun 5;134(11):1015-23. doi: 10.7326/0003-4819-134-11-200106050-00007.
10
Mean blood pressure, pulse pressure and grade of hypertension in untreated hypertensive patients with sleep-related breathing disorder.
J Hypertens. 2001 Apr;19(4):683-90. doi: 10.1097/00004872-200104000-00004.
Zotero 插件